| PACKAGING TYPE: | 10x15 Alu-alu (10 Strips In 1 Box) |
| COMPOSITION: | Voglibose (0.3mg) |
| FORMULATION: | Tablet |
| Description: | VONISH-0.3 Tablet contains Voglibose 0.3mg, an oral antidiabetic medication used for type 2 diabetes mellitus. Voglibose is an alpha-glucosidase inhibitor, which works by delaying the breakdown and absorption of carbohydrates in the intestine. This helps in controlling postprandial blood sugar spikes, leading to improved overall glycemic control. |
| Side Effects: | Common side effects: Flatulence (gas) Mild abdominal discomfort Diarrhea Nausea Rare side effects: Severe abdominal pain Allergic reactions |
| How to Use: | Take the tablet as prescribed by your doctor Usually taken before meals, 2–3 times daily depending on diet and medical advice Swallow the tablet with water Monitor blood sugar levels regularly |
| Precaution: | Use cautiously in patients with intestinal obstruction or chronic intestinal disorders Inform your doctor about other medications and health conditions Not recommended during pregnancy or breastfeeding unless prescribed Monitor blood sugar for optimal glycemic control |
| Product Benefits: | Effective control of post-meal blood glucose levels Slows intestinal carbohydrate absorption Helps in managing type 2 diabetes Can be combined with other oral antidiabetic agents for enhanced glycemic control Supports glycemic stability Low risk of h |
Frequently Asked Questions
It is used to manage type 2 diabetes by controlling postprandial blood sugar spikes.
Voglibose inhibits alpha-glucosidase enzymes in the intestine, slowing carbohydrate absorption and reducing post-meal blood glucose.
Yes, it can be combined with other oral antidiabetic agents under medical supervision for improved glycemic control.
















